Other Liabilities, Noncurrent of Organon & Co. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Organon & Co. quarterly Other Liabilities, Noncurrent in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Organon & Co. Other Liabilities, Noncurrent for the quarter ending 30 Sep 2025 was $1,122,000,000, a 66% increase year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

Organon & Co. Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,122,000,000 +$448,000,000 +66% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,121,000,000 +$573,000,000 +105% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $994,000,000 +$445,000,000 +81% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $977,000,000 +$565,000,000 +137% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $674,000,000 +$253,000,000 +60% 30 Sep 2024 10-Q 01 Nov 2024 2024 Q3
Q2 2024 $548,000,000 +$155,000,000 +39% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $549,000,000 +$128,000,000 +30% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $412,000,000 +$1,000,000 +0.24% 31 Dec 2023 10-K/A 10 Nov 2025 2024 FY
Q3 2023 $421,000,000 -$20,000,000 -4.5% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $393,000,000 -$55,000,000 -12% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $421,000,000 -$33,000,000 -7.3% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $411,000,000 -$52,000,000 -11% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $441,000,000 -$65,000,000 -13% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $448,000,000 -$39,000,000 -8% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $454,000,000 -$1,393,000,000 -75% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $463,000,000 -$1,276,000,000 -73% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $506,000,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $487,000,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $1,847,000,000 31 Mar 2021 10-Q 21 Jun 2021 2021 Q1
Q4 2020 $1,739,000,000 31 Dec 2020 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.